ArticleCureus2025

Reassessing Cisplatin Eligibility in Urothelial Carcinoma: A Retrospective Study on Dose Reduction Strategies.

Satoshi Yamamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.